Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 14, 2013; 19(46): 8647-8651
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8647
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8647
Guideline | Guideline | Unadjusted | Adjusted | |
Compliant, | Non-compliant, | P value | P value | |
n = 139 | n = 181 | |||
Demographics | ||||
Mean ± SD, yr | 56.8 ± 14.1 | 59.4 ± 16.2 | 0.13 | |
Female | 61 (44.2) | 77 (55.8) | 0.81 | |
Disease severity | ||||
Mild-moderate | 89 (65.9) | 46 (34.1) | < 0.0011 | < 0.0011 |
Severe | 39 (25.3) | 115 (74.7) | ||
Severe-complicated | 11 (35.5) | 20 (64.5) | ||
Severe + severe-complicated | 50 (27.0) | 135 (73.0) | ||
Other factors | ||||
Hospitalized | 133 (43.3) | 174 (56.7) | 0.84 | |
ICU | 60 (40.0) | 90 (60.0) | 0.24 | |
Prior antibiotics (< 30 d) | 88 (39.1) | 137 (60.9) | 0.02 | 0.08 |
Recurrence | 17 (34.0) | 33 (66.0) | 0.14 | 0.04 |
Immunosuppressed | 57 (51.8) | 53 (49.2) | 0.03 | 0.49 |
30-d mortality | 15 (41.7) | 21 (58.3) | 0.82 |
-
Citation: Curtin BF, Zarbalian Y, Flasar MH, Rosenvinge EV.
Clostridium difficile -associated disease: Adherence with current guidelines at a tertiary medical center. World J Gastroenterol 2013; 19(46): 8647-8651 - URL: https://www.wjgnet.com/1007-9327/full/v19/i46/8647.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i46.8647